Matches in SemOpenAlex for { <https://semopenalex.org/work/W4291291256> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W4291291256 endingPage "S45" @default.
- W4291291256 startingPage "S45" @default.
- W4291291256 abstract "To prove the involvement of insulins in intoxication is challenging in postmortem cases. Two insulins assays were developed and validated, quantitatively in blood and qualitatively in tissues. The aim is to share feedback from 4 years of these methods’ application, in clinical and forensic contexts. This retrospective study focused on cases for which insulins analysis was requested in these last 4 years. The studied parameters were: context of the request, samples transfer and analysis intervals, type and concentration results. For postmortem cases, samples were collected during autopsy according to a homemade protocol consisting in cardiac and peripheral blood, liver, kidney, muscle, injection site (IS). For clinical cases, samples were serum collected during hospitalization. Assay allows detection of human insulin and analogs: aspart, glulisine, lispro, detemir, degludec, glargine and M1. Blood samples assay consisted in 3 steps: protein precipitation, filtration and immunopurification before analysis on LC-HRMS (Bottinelli. Talanta 2021:225). Steps of cutting and ultrasonication in acidic ethanol were added for tissue samples (Bottinelli. Int J Legal Med 2021;135:1813–22). Sixty-six cases were analyzed between January 2018 and March 2022: 59 were postmortem cases for which insulin use was suspected (history of diabetes, insulin material found at corpse discovery place…) and 7 were clinical cases for which insulins analysis was requested for a diagnosis of severe hypoglycemia. Treatment by insulins was known in 23 cases and 13 cases were not diabetic. A total of 10 clinical sera, 94 postmortem bloods (n = 53 peripheral; n = 41 cardiac), 16 IS, 20 muscles, 33 livers and 33 kidneys were analyzed. At least one insulin was identified in 29 cases (43%) corresponding to 8 positive sera (80%), 10 IS (62%), 7 muscles (35%), 12 cardiac bloods (29%), 11 peripheral bloods (21%), 7 kidneys (21%), and 4 livers (12%). In 7 cases, insulin administration was characterized by analysis of tissues as blood analysis was negative. In most postmortem cases, insulins were detected when postmortem interval was less than 72 h. Moreover, 50% of samples were positive when blood is centrifuged and freeze less than 24 h after sampling. All insulins were identified at least one time, but aspart (27%) and glargine/M1 (11%) were the most represented. For aspart, postmortem blood concentrations ranged from < 1.0 ng/mL (LOQ) to 432 ng/mL (mean: 50.1 ng/mL), with the highest measured for two non-diabetic people. Insulins intoxications are underestimated as underlined by numerous authors. Since the application of the new LC-HRMS methods, numerous cases of insulins use and intoxication were revealed. Preparation of postmortem samples is the crucial point requiring several steps with specific material. The expensive and time-consuming methods lead to a non-systematic perform, but only when data from autopsy or enquiries suggest possible insulin administration. Initially not dedicated to clinical cases, methods allowed to elucidate origins of severe hypoglycemia in various situations: Münchausen, degludec spontaneous release, suicide attempt, self-medication. The major detection of aspart and glargine is consistent with the prescription trends in France. More degludec detection was expected but was limited either because it was less implicated in intoxications or due to matrix effects. Autopsy realization within 72 h after death, centrifugation/freezing of blood samples within 24 h after sampling and analyses of several matrices including blood and tissues, seem to be crucial conditions to maximize chances for highlighting presence of insulins in postmortem cases. Even if the “simple” detection of an insulin is informative in numerous cases, interpretation of concentration would be relevant. However, insulins displayed a large range concentrations as numerous parameters could have an influence such as diabetes status, type of analog, metabolism, hemolysis… Define a therapeutic or toxic range seems complex and further studies are required. This could be possible with the increase of interest for this problematic in medico-legal research teams." @default.
- W4291291256 created "2022-08-14" @default.
- W4291291256 creator A5004357356 @default.
- W4291291256 creator A5005646897 @default.
- W4291291256 creator A5011436081 @default.
- W4291291256 creator A5053602514 @default.
- W4291291256 creator A5064418716 @default.
- W4291291256 creator A5088242621 @default.
- W4291291256 date "2022-09-01" @default.
- W4291291256 modified "2023-10-18" @default.
- W4291291256 title "Analysis of human insulin and its therapeutic analogs by LC-HRMS: 4 years feedback and perspectives" @default.
- W4291291256 doi "https://doi.org/10.1016/j.toxac.2022.06.049" @default.
- W4291291256 hasPublicationYear "2022" @default.
- W4291291256 type Work @default.
- W4291291256 citedByCount "0" @default.
- W4291291256 crossrefType "journal-article" @default.
- W4291291256 hasAuthorship W4291291256A5004357356 @default.
- W4291291256 hasAuthorship W4291291256A5005646897 @default.
- W4291291256 hasAuthorship W4291291256A5011436081 @default.
- W4291291256 hasAuthorship W4291291256A5053602514 @default.
- W4291291256 hasAuthorship W4291291256A5064418716 @default.
- W4291291256 hasAuthorship W4291291256A5088242621 @default.
- W4291291256 hasBestOaLocation W42912912561 @default.
- W4291291256 hasConcept C126322002 @default.
- W4291291256 hasConcept C134018914 @default.
- W4291291256 hasConcept C141071460 @default.
- W4291291256 hasConcept C147789679 @default.
- W4291291256 hasConcept C151730666 @default.
- W4291291256 hasConcept C185592680 @default.
- W4291291256 hasConcept C2776664568 @default.
- W4291291256 hasConcept C2779306644 @default.
- W4291291256 hasConcept C2779343474 @default.
- W4291291256 hasConcept C2779504383 @default.
- W4291291256 hasConcept C2779908123 @default.
- W4291291256 hasConcept C2780668416 @default.
- W4291291256 hasConcept C3019948211 @default.
- W4291291256 hasConcept C555293320 @default.
- W4291291256 hasConcept C71924100 @default.
- W4291291256 hasConcept C72092618 @default.
- W4291291256 hasConcept C86803240 @default.
- W4291291256 hasConceptScore W4291291256C126322002 @default.
- W4291291256 hasConceptScore W4291291256C134018914 @default.
- W4291291256 hasConceptScore W4291291256C141071460 @default.
- W4291291256 hasConceptScore W4291291256C147789679 @default.
- W4291291256 hasConceptScore W4291291256C151730666 @default.
- W4291291256 hasConceptScore W4291291256C185592680 @default.
- W4291291256 hasConceptScore W4291291256C2776664568 @default.
- W4291291256 hasConceptScore W4291291256C2779306644 @default.
- W4291291256 hasConceptScore W4291291256C2779343474 @default.
- W4291291256 hasConceptScore W4291291256C2779504383 @default.
- W4291291256 hasConceptScore W4291291256C2779908123 @default.
- W4291291256 hasConceptScore W4291291256C2780668416 @default.
- W4291291256 hasConceptScore W4291291256C3019948211 @default.
- W4291291256 hasConceptScore W4291291256C555293320 @default.
- W4291291256 hasConceptScore W4291291256C71924100 @default.
- W4291291256 hasConceptScore W4291291256C72092618 @default.
- W4291291256 hasConceptScore W4291291256C86803240 @default.
- W4291291256 hasIssue "3" @default.
- W4291291256 hasLocation W42912912561 @default.
- W4291291256 hasOpenAccess W4291291256 @default.
- W4291291256 hasPrimaryLocation W42912912561 @default.
- W4291291256 hasRelatedWork W1599472676 @default.
- W4291291256 hasRelatedWork W1964773646 @default.
- W4291291256 hasRelatedWork W1966107766 @default.
- W4291291256 hasRelatedWork W2121456845 @default.
- W4291291256 hasRelatedWork W2159012137 @default.
- W4291291256 hasRelatedWork W2237035136 @default.
- W4291291256 hasRelatedWork W2360370752 @default.
- W4291291256 hasRelatedWork W2374483849 @default.
- W4291291256 hasRelatedWork W2383076809 @default.
- W4291291256 hasRelatedWork W4240392880 @default.
- W4291291256 hasVolume "34" @default.
- W4291291256 isParatext "false" @default.
- W4291291256 isRetracted "false" @default.
- W4291291256 workType "article" @default.